Home » Topics » BioWorld Science

BioWorld Science
RSS

Istari Oncology expands LUMINOS-103 trial of PVSRIPO to include HNSCC

Aug. 18, 2021

Sirnaomics describes new siRNAs targeting SARS-CoV-2

Aug. 18, 2021

Enanta Pharmaceuticals synthesizes new antiviral compounds

Aug. 18, 2021

Jiangsu Simcere Pharmaceutical presents BTK and JAK3 inhibitors

Aug. 18, 2021

Sichuan Kelun-Biotech Biopharmaceutical patents TGFR1 inhibitors

Aug. 18, 2021

DNMT3a and DNA methylation alterations in the nucleus accumbens are involved in PTSD-like behavior

Aug. 18, 2021

Joint venture announcement behind AR-035 and AR-882 development in China

Aug. 18, 2021

Collaboration announced for phase II study of larazotide for COVID-19-derived MIS-C

Aug. 18, 2021

Complexes cross BBB, knock down CNS genes in rodents

Aug. 18, 2021

First patient dosed with CIT-013, a first-in-class antagonist targeting NETs

Aug. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...